RELATED CONTENT
NEWS
- SuperGen rises 8.8% on US FDA acceptance of Dacogen sNDA in AML
- Pharmacyclics raises $57M to advance tyrosine kinase inhibitor for blood cancers
- Talon delivers NDA to US FDA for Marqibo in adult Ph- ALL
- NICE to review Fabre's Javlor again as comparison with unlicensed drugs deemed unfair

